Save your place

Sign in to WhoBought

Please try again later.

Cathie Wood's Ionis Pharmaceuticals, Inc. (IONS) position

Yes: as of Q1 2026, Cathie Wood holds 289K shares of IONS worth $22M (0.2% of the disclosed portfolio). Held since at least Q1 2021; that opening coverage snapshot is not counted as a purchase.
View full portfolio →
Current value
$22M
Shares held
289K
% of portfolio
0.2%
Est. average buy price (i)
$48.82
est. since Q3 2025
Quarter-end price
$75.09

Estimated trade prices

Average price in quarters with purchases
$39.21
Average prices in quarters with sales
  • Q1 2026: $78.92 (134K shares sold)
  • Q4 2025: $75.30 (208K shares sold)
  • Q2 2025: $32.73 (100K shares sold)
  • Q1 2025: $32.75 (25K shares sold)
  • Q4 2024: $37.38 (359K shares sold)
  • Q2 2024: $41.01 (39K shares sold)
  • Q1 2024: $47.67 (505K shares sold)
  • Q4 2023: $47.90 (461K shares sold)
  • Q3 2023: $41.26 (56K shares sold)
  • Q2 2023: $38.43 (215K shares sold)
  • Q1 2023: $37.55 (36K shares sold)
  • Q4 2022: $42.06 (1.0M shares sold)
  • Q3 2022: $42.14 (988K shares sold)
  • Q2 2022: $37.71 (1.5M shares sold)
  • Q1 2022: $32.73 (912K shares sold)
  • Q4 2021: $31.48 (1.4M shares sold)
  • Q3 2021: $37.68 (396K shares sold)

IONS price vs Wood's position

1Y 3Y 5Y MAX
Dates
$20$50$10020222023202420252026Sold 396K shares (4.4%) · Q3 2021. Average closing price $37.68 · Price range $33.54–$40.55396KsharessoldSold 1.4M shares (16.8%) · Q4 2021. Average closing price $31.48 · Price range $25.61–$35.101.4MsharessoldSold 912K shares (12.9%) · Q1 2022. Average closing price $32.73 · Price range $29.88–$37.04912KsharessoldSold 1.5M shares (23.8%) · Q2 2022. Average closing price $37.71 · Price range $31.71–$43.001.5MsharessoldSold 988K shares (21.0%) · Q3 2022. Average closing price $42.14 · Price range $36.54–$48.66988KsharessoldSold 1.0M shares (28.0%) · Q4 2022. Average closing price $42.06 · Price range $37.12–$46.521.0MsharessoldSold 36K shares (1.4%) · Q1 2023. Average closing price $37.55 · Price range $33.58–$41.2036KsharessoldSold 215K shares (8.1%) · Q2 2023. Average closing price $38.43 · Price range $34.73–$43.33215KsharessoldSold 56K shares (2.3%) · Q3 2023. Average closing price $41.26 · Price range $38.50–$47.1356KsharessoldSold 461K shares (19.5%) · Q4 2023. Average closing price $47.90 · Price range $43.39–$51.63461KsharessoldSold 505K shares (26.5%) · Q1 2024. Average closing price $47.67 · Price range $42.03–$53.55505KsharessoldSold 39K shares (2.8%) · Q2 2024. Average closing price $41.01 · Price range $36.45–$47.7039KsharessoldAdded 23K shares (1.7%) · Q3 2024. Average closing price $46.53 · Price range $40.06–$51.8623KsharespurchasedSold 359K shares (25.9%) · Q4 2024. Average closing price $37.38 · Price range $33.73–$40.36359KsharessoldSold 25K shares (2.4%) · Q1 2025. Average closing price $32.75 · Price range $30.17–$34.9725KsharessoldSold 100K shares (10.0%) · Q2 2025. Average closing price $32.73 · Price range $25.51–$40.00100KsharessoldSold 208K shares (33.0%) · Q4 2025. Average closing price $75.30 · Price range $65.80–$82.73208KsharessoldSold 134K shares (31.7%) · Q1 2026. Average closing price $78.92 · Price range $69.68–$86.50134Ksharessold← Earlier —1 purchase
Average closing price · filing quarter
$78.92
Price range · filing quarter
$69.68 – $86.50
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Reduced −134K −$11M −31.7% 289K May 12, 2026
Q4 2025 Reduced −208K −$16M −33.0% 423K Feb 11, 2026
Q3 2025 First covered – – – 631K Nov 12, 2025
Q2 2025 Reduced −100K −$3.3M −10.0% 900K Jul 30, 2025
Q1 2025 Reduced −25K −$810K −2.4% 1.0M May 7, 2025
Q4 2024 Reduced −359K −$13M −25.9% 1.0M Feb 4, 2025
Q3 2024 Added +23K +$1.1M +1.7% 1.4M Oct 31, 2024
Q2 2024 Reduced −39K −$1.6M −2.8% 1.4M Jul 26, 2024
Q1 2024 Reduced −505K −$24M −26.5% 1.4M Apr 18, 2024
Q4 2023 Reduced −461K −$22M −19.5% 1.9M Jan 17, 2024
Q3 2023 Reduced −56K −$2.3M −2.3% 2.4M Oct 18, 2023
Q2 2023 Reduced −215K −$8.2M −8.1% 2.4M Jul 10, 2023
Q1 2023 Reduced −36K −$1.4M −1.4% 2.6M Apr 17, 2023
Q4 2022 Reduced −1.0M −$44M −28.0% 2.7M Jan 24, 2023
Q3 2022 Reduced −988K −$42M −21.0% 3.7M Oct 17, 2022
Q2 2022 Reduced −1.5M −$55M −23.8% 4.7M Jul 11, 2022
Q1 2022 Reduced −912K −$30M −12.9% 6.2M Apr 19, 2022
Q4 2021 Reduced −1.4M −$45M −16.8% 7.1M Jan 28, 2022
Q3 2021 Reduced −396K −$15M −4.4% 8.5M Nov 12, 2021
Q2 2021 Added +3.8M +$147M +73.2% 8.9M Aug 5, 2021
Q1 2021 First covered – – – 5.1M May 13, 2021
Data through Q1 2026 · filed May 12, 2026
21 grouped rows from 21 quarters

More Wood positions

Tesla, Inc.(TSLA)
$1.1B
8.2% of portfolio

Advanced Micro Devices, Inc.(AMD)
$540M
4.3% of portfolio

CRISPR Therapeutics AG(CRSP)
$538M
4.2% of portfolio

Shopify Inc.(SHOP)
$496M
3.9% of portfolio

Palantir Technologies Inc.(PLTR)
$444M
3.5% of portfolio

Tempus AI, Inc.(TEM)
$434M
3.4% of portfolio

Common questions

Does Cathie Wood own IONS?

Yes. As of Q1 2026, Cathie Wood disclosed 289K shares of IONS, worth $22M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Cathie Wood buy IONS?

Cathie Wood held IONS since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Cathie Wood sell IONS?

The quarter-by-quarter table above shows each sale and reduction Cathie Wood disclosed in IONS. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of IONS does Cathie Wood own?

Cathie Wood disclosed 289K shares of IONS as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Cathie Wood pay for IONS?

Cathie Wood began building the IONS position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.